| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $1.2 (Beat by $0.01) |
| EPS GAAP Actual | $1.2 (Beat by $0.01) |
| Revenue Actual | $2.0712B |
| Revenue Surprise | Beat by $2071.2M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $2.37451 |
| EPS GAAP Estimate | $2.37451 |
| Revenue Estimate | $2.42673046B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 11.16 | 8.03 | 10.51114 | 11.80803 | 7 |
| Dec 2028 | 15.46 | 5.79 | 13.6091 | 16.44183 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.2 | 1.2 | 2.0712B | -9.31% | 2071.2M |
| FQ1 2025 (Mar 2025) | 0.67 | 0.67 | 1.96439B | 5.19% | 1964.39M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 2.07689B | 5.21% | 2076.89M |
| FQ3 2024 (Sep 2024) | 1.52 | 1.52 | 2.20216B | 13.22% | 2202.16M |
| FQ2 2024 (Jun 2024) | 1.39 | 1.39 | 2.26408B | 20.88% | 2264.08M |
| FQ1 2024 (Mar 2024) | 1.09 | 1.09 | 1.86246B | 0.66% | 1862.46M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 1.96868B | 100% | 1968.68M |
| FQ3 2023 (Sep 2023) | 1.55 | 1.55 | 1.91105B | 100% | 1911.05M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
2.37451
Consensus Revenue Estimates
2.42673046B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.4268 | -- | 3.29794 | 3.61088 | 1 |
| FQ3 2027 (Sep 2027) | 3.0941 | -- | 2.58565 | 3.3303 | 8 |
| FQ2 2027 (Jun 2027) | 3.019 | -- | 2.52289 | 3.24946 | 5 |
| FQ1 2027 (Mar 2027) | 2.6658 | -- | 2.56556 | 2.809 | 1 |
| FQ4 2026 (Oct 2026) | 2.67463 | -- | 2.42228 | 2.83027 | 3 |
| FQ3 2026 (Jul 2026) | 2.4858 | -- | 2.25126 | 2.63045 | 3 |
| FQ2 2026 (Jun 2026) | 2.70913 | 55.71 | 2.4074 | 3.00076 | 3 |
| FQ1 2026 (Mar 2026) | 2.2087 | 69.67 | 2.12565 | 2.32735 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.96B | -- | 2.88B | 3.08B | 1 |
| FQ3 2027 (Sep 2027) | 2.92B | -- | 2.55B | 3.09B | 4 |
| FQ2 2027 (Jun 2027) | 2.85B | -- | 2.49B | 3.01B | 6 |
| FQ1 2027 (Mar 2027) | 2.76B | -- | 2.68B | 2.88B | 1 |
| FQ4 2026 (Oct 2026) | 2.59B | -- | 2.4B | 2.7B | 4 |
| FQ3 2026 (Jul 2026) | 2.56B | -- | 2.38B | 2.68B | 5 |
| FQ2 2026 (Jun 2026) | 2.6B | 20.19 | 2.37B | 2.81B | 4 |
| FQ1 2026 (Mar 2026) | 2.46B | 20.3 | 2.39B | 2.57B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
0
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.2 | 1.2 | 100% | |
| FQ1 2025 (Mar 2025) | 0.67 | 0.67 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 1.52 | 1.52 | 100% | |
| FQ2 2024 (Jun 2024) | 1.39 | 1.39 | 100% | |
| FQ1 2024 (Mar 2024) | 1.09 | 1.09 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
| FQ3 2023 (Sep 2023) | 1.55 | 1.55 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $2.07B | $2071.2M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.96B | $1964.39M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2.08B | $2076.89M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.2B | $2202.16M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.26B | $2264.08M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.86B | $1862.46M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.97B | $1968.68M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $1.91B | $1911.05M | 100% |